Shandong Weigao Group Medical Polymer (1066.HK) Earnings Analysis
Shandong Weigao Group Medical Polymer (1066.HK) next reports earnings on 2026-09-02, consensus EPS 0.1847 HKD. Last quarter (2026-03-27) it missed with EPS 0.1447 HKD vs 0.2003 HKD est (-27.8%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E 8.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1066.HK next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | 0.1847 HKD |
| Revenue estimate | 8.19B |
1066.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-27 | 0.1447 HKD | 0.2003 HKD | -27.8% | Miss |
| 2025-08-27 | 0.2428 HKD | 0.2849 HKD | -14.8% | Miss |
| 2024-12-31 | 0.2233 HKD | n/a | n/a | n/a |
| 2024-08-28 | 0.2577 HKD | 0.2579 HKD | -0.1% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
1066.HK valuation and analyst view
| Trailing P/E | 8.12 |
|---|---|
| Trailing EPS | 0.34681 HKD |
| Price / book | 0.55 |
| Dividend yield | 5.32% |
| Market cap | 14.54B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shandong Weigao Group Medical Polymer (1066.HK)'s next earnings date?
Shandong Weigao Group Medical Polymer is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 0.1847 HKD and revenue estimate of 8.19B.
Did 1066.HK beat earnings last quarter?
In its 2026-03-27 report, 1066.HK posted EPS of 0.1447 HKD versus a 0.2003 HKD estimate — a miss of 27.8%.
What is 1066.HK's earnings track record?
Over the last 3 reported quarters with consensus data, 1066.HK beat estimates 0 times (0%).
What is 1066.HK's current P/E ratio and EPS?
1066.HK trades at a trailing P/E of 8.12 on trailing EPS of 0.3468147116972633 HKD.
What do analysts rate 1066.HK?
1066.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.